What We're Reading: Page 310
Industry reads hand-picked by our editors
Feb 03, 2017
-
Bloomberg
Trump volatility index takes pharma companies on a wild ride
-
Xconomy
Drug-hunting startup from Scripps attracts Celgene alum, $50M backing
-
TheStreet
Side effect kills cancer patient in Stemline Therapeutics drug trial; company raises money
-
The Huffington Post
New rules aim To keep patients on medications that work
Feb 02, 2017
Feb 01, 2017
Jan 31, 2017
-
Reuters
Trump to meet Novartis CEO, other pharma bosses on Tuesday
-
The Wall Street Journal
Rep. Tom Price got privileged, discounted offer on biomedical stock, company says
-
Bloomberg
Natco Pharma rallies as U.S. judge invalidates Teva’s Copaxone patents
-
CNN
After trial death and before Trump change, a call for drug approval reform
Jan 30, 2017
-
Bloomberg
Old cancer drug gets 1,227% price hike in frugal U.K.
-
CNBC
Danish drugmaker Novo Nordisk bets $145 mln on post-Brexit UK science
-
Kaiser Health News
Getting patients hooked on an opioid overdose antidote, then raising the price
-
Chemical & Engineering News
The year in new drugs
Jan 27, 2017
-
Bloomberg BNA
Will Trump’s hiring freeze put FDA’s new cures jobs on ice?
-
Politico
Cuomo's pharma proposals face uncertain future
-
Regulatory Focus
Pharma companies take issue with FDA proposal to overhaul nonclinical study regulations
-
Bloomberg
Hedge funds strike paydirt on Actelion deal after tracking J&J's jet
Previous
